These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6653862)

  • 1. Comments on "Kinetic behaviour of the glucose-hemoglobin labile adduct in normal and diabetic erythrocytes".
    Mortensen HB; Christophersen C
    Diabete Metab; 1983 Sep; 9(3):232-3. PubMed ID: 6653862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycosylated hemoglobins. Their importance in the diabetic patient].
    Gajdos A
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2613-6. PubMed ID: 493053
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic behaviour of the glucose-hemoglobin labile adduct in normal and diabetic erythrocytes.
    Bolli G; Cartechini MG; Compagnucci P; De Feo P; Santeusanio F; Brunetti P
    Diabete Metab; 1982 Mar; 8(1):21-7. PubMed ID: 7095241
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative investigation of nonenzymatic glucosylation of erythrocyte membrane from normal and diabetic persons.
    Schleicher E; Scheller L; Wieland OH
    Horm Metab Res Suppl; 1981; 11():95-7. PubMed ID: 6797914
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cell glycolytic intermediates in diabetic patients.
    Tegos C; Beutler E
    J Lab Clin Med; 1980 Jul; 96(1):85-9. PubMed ID: 7391659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Glycosylated hemoglobin and diabetic control.
    Gabbay KH
    N Engl J Med; 1976 Aug; 295(8):443-4. PubMed ID: 934243
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythrocyte glycolysis in normal & diabetic subjects & its relation to acetylcholinesterase activity].
    GHIOTTO G; DE SANDRE G
    Arch Sci Med (Torino); 1958 Aug; 106(2):201-14. PubMed ID: 13560229
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of aggregation parameters of erythrocytes in diabetes mellitus.
    Babu N; Singh M
    Clin Hemorheol Microcirc; 2005; 32(4):269-77. PubMed ID: 15894825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathionyl haemoglobin is not increased in diabetes nor related to glycaemia, complications, dyslipidaemia, inflammation or other measures of oxidative stress.
    Hoffmann P; Woon J; Rowley KG; Karschimkus C; Nelson CL; Dragicevic G; O'Neal D; Wilson A; Croft KD; Mori TA; Kemp BE; Best JD; Jenkins AJ
    Diabetes Res Clin Pract; 2008 May; 80(2):e1-3. PubMed ID: 18313786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impermeability of erythrocytes to glucose-l-phosphate; research on erythrocytes of normal & diabetic subjects].
    DE SANDRE G; GHIOTTO G
    Arch Sci Med (Torino); 1958 Aug; 106(2):215-22. PubMed ID: 13560230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evident metabolism and structure abnormalities of red blood cells in diabetic patients].
    Heller H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(4):417-28. PubMed ID: 4132195
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of hemoglobin and other proteins by nonenzymatic glycosylation.
    Bunn HF
    Prog Clin Biol Res; 1981; 51():223-39. PubMed ID: 7022470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels.
    Jain SK; Rains J; Jones K
    Free Radic Biol Med; 2006 Jul; 41(1):92-6. PubMed ID: 16781457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
    J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO contest: nitrite versus S-nitroso-hemoglobin.
    Gladwin MT; Schechter AN
    Circ Res; 2004 Apr; 94(7):851-5. PubMed ID: 15087423
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood glucose replacement rates in normal and diabetic humans.
    REICHARD GA; ISSEKUTZ B; KIMBEL P; HOCHELLA NJ; WEINHOUSE S
    J Appl Physiol; 1961 Sep; 16():789-95. PubMed ID: 14038649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of nonenzymatic glycosylation of proteins in disorders of erythrocytes and blood platelets in diabetes mellitus].
    Watała C
    Acta Haematol Pol; 1993; 24(2):95-101. PubMed ID: 8372620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship between Erythrocytes and Diabetes Mellitus.
    Wang Y; Yang P; Yan Z; Liu Z; Ma Q; Zhang Z; Wang Y; Su Y
    J Diabetes Res; 2021; 2021():6656062. PubMed ID: 33728350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired oxygen release caused by alterations of the metabolism in the erythrocytes in diabetes.
    Ditzel J
    Lancet; 1972 Apr; 1(7753):721-3. PubMed ID: 4111196
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood glucose control and diabetic microangiopathy.
    Cheah JS
    Med J Malaysia; 1981 Dec; 36(4):220-6. PubMed ID: 7334957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.